Featured Innovation Writing Process: Overcoming the Challenges – Part 2

Whether is coming up with an idea or grasping the technical aspects, writing a feature for a new technology can be daunting. No one knows more about a new innovation than the inventor themself, but even with access to the inventor, there are difficulties encountered. Here are a few challenges and tips to be aware of as you help bridge the gap between the inventor and general audience in communicating new innovations (part one of this series can be found here). Understanding the Research The initial assignment is met with a mixture of excitement and anxiety; a new technology and the chance to interview its inventor is thrilling, but occasionally the technologies are highly complex and become somewhat difficult to understand without a PhD. A good place to start is a quick Google search on that area of research—look for references from reputable sources, including Wikipedia or YouTube, to gain a basic understanding of the science. Also look for previously published papers from the inventor as a resource. Sometimes you can even find a past interview with the inventor which can be very helpful in thinking about how to approach the piece. Crafting the Questions At this point, it is

Continue reading

Featured Innovations: Conveying the What? Who? How? And Why? – Part 1

Discoveries are made every day; some discoveries have vast implications, while others might only impact a small group. Some innovations emerge through a serendipitous accident, and others are the product of a lifetime of work. There is incredible variability in how discoveries are made, and that variability should be represented in the narrative of the scientific innovation. The role of technology transfer is to help researchers  move their discoveries and inventions to the marketplace. What we call a “featured innovation” is an opportunity to explain a new technology in an accessible and engaging way. The audience is broad, from the general public to potential investors, lawyers, inventors, academics, and OTT professionals. These pieces should answer four main questions–What? Who? How? Why should I care?–while simultaneously including the inventor’s journey. When writing a featured innovation piece, the first step is to do some preliminary background research on the new technology. This research will allow one to craft specific interview questions for the inventor and gain a greater understanding of the new technology and its purpose. Next, it is usually most productive to interview the innovation’s case manager. Case managers oversee the process of moving the innovation out of the University to

Continue reading

AUTM 2016 Eastern Region: Marketing Takeaways

While AUTM’s annual meeting offers a superb opportunity to immerse ones’ self in our industry, the busy schedule and large number of attendees can be a lot to take in; AUTM’s regional meetings however offer a more intimate environment to delve deeper into specific topics impacting our world and build new connections. For two days, technology managers and business executives who manage intellectual property met in Philadelphia, PA for the 2016 AUTM Eastern Region Meeting. In attendance from “team Emory” were our Director, Todd Sherer, as well as our Marketing Manager, Quentin Thomas, who was also a part of a panel on Guerilla Marketing. Here are a few tactics and tips from the Guerilla Marketing panel picked up at AUTM’s Eastern Regional meeting. Email Tracking Tracking your emails can provide valuable information beyond just open rate. Knowing who opened your emails and how often they were opened can provide ideas as to whom you should, and sometimes more importantly, should not follow-up with, as well as how to follow-up. Resources for tracking emails include services such as MailChimp, Campaign Monitor, and Emma, as well as plug-ins for Outlook. Licensing Deals from Marketing There was conversation around the ability to track

Continue reading

Content Marketing: Takeaways from Traditional Methods for Tech Transfer

Quentin, our marketing manager, and myself recently attended a webinar on content marketing. While the agenda may have skewed to more of a traditional sales and marketing focus there were still plenty of lessons to be learned for a tech transfer office. What were some of the key takeaways for tech transfer professionals? Here are our top five from each of the four presentations. Developing a Content Strategy The dilemma we face is quality vs. speed vs. cost and which two do we want? Go back and optimize/update/add new links to existing content for new life. Analyze what has been popular and see what the trends/themes might be and see if you can build a new piece around that. Don’t forget to look within for team members! Put yourself in your audience’s shoes and write to them. Video Content to Tell Stories Start small – learn and build. Don’t lose site of the forest or audience by getting caught up in the details. Video length in social 30 seconds to 1 ½ minute; Facebook is 30 seconds! Don’t forget closed captions on your videos; remember specials needs and in some platforms video starts without sound. Optimizing Your Content for Search  The

Continue reading

Leveraging Emory OTT to Build Your Product Pipeline Revisited

At any given time Emory has approximately 600 technologies available to license. However whether a startup or an established company, finding new technologies available at a university is time-consuming and sometimes frustrating. We often are asked about the best ways to learn about our technologies available for licensing. We are pleased to announce one of our newest resources – TechFeed. By subscribing to the TechFeed notification system you can receive emails with recently added technologies matching your specified criteria and at your desired frequency. Sign-up once and the system will keep you informed. Additional easy ways to find and remain up-to-date with all the technologies coming out of Emory University. Use our Search option in the Technology Listings page to find non-confidential summaries of the technologies available. It’s run by Google and provides an improved searching experience and more accurate results. Looking for anything around a specific indication or topic? On the same Technology Listings page, click on Keywords in our word cloud and Technology Categories to get a list of those technologies. Subscribe to our RSS feed and follow us on Twitter @EmoryOTT to see all our new technologies as soon as they are listed on the website. Visit

Continue reading

Rare Disease Day 2016

February 29th occurs once out of every 1461 days. It makes sense that we celebrate Rare Disease Day on the rarest date on our calendar. There are many diseases and disorders which occur at a significantly lower rate than 1 in 1461, while yet having a great impact on lives of those afflicted. 2016 marks the ninth year that the international rare disease community celebrates Rare Disease Day, an event started to raise awareness for these diseases and disorders. In the USA, a rare disease is one which affects fewer than 200,000 Americans at any given time. Rare diseases can be not only difficult to treat, but to diagnose. The over 6,000 identified rare diseases include a broad array of disorders and symptoms that vary not only between diseases but between patients suffering from the same disease. Common symptoms can mask underlying rare diseases and lead to misdiagnosis or delayed treatment. For most of these diseases, there are no effective cures available. Emory researchers have developed several currently available technologies addressing rare and orphan diseases including fragile X syndrome, diabetes insipidus and more. One of the most notable rare disease treatments was developed by a research team led by Emory

Continue reading

AUTM 2016 – Top Ten Marketing Tips

AUTM’s (the Association of University Technology Managers) Annual meeting in San Diego, as others before it, was a whirlwind of non-stop education, networking, and partnering. AUTM 2016 was a busy meeting for the OTT team as members volunteered, attended sessions, spoke on panels, and participated in partnering sessions over the four day event. The weather was wonderful and everyone thoroughly enjoyed the “winter break.” There were a record number of marketing sessions at this meeting and here is our top ten list of marketing tips. Office Marketing Always have a call to action, always drive traffic back to your web site Branding is often misunderstood, but your brand is everything you say and do and how you say and do it Repurpose content – package parts and use in different ways and locations Share your successes Students can be a great resource to expand your marketing capabilities Technology Marketing Don’t just talk about what technologies you have available, but listen to what companies need When preparing a technology brief the writer should be skeptical and prove the value to themselves Your technology brief must include the value proposition for the technology Companies categorize inventors as established, up and comer, and

Continue reading

Partnering: Turning Over Stones

There are several conferences to which many members of the technology transfer industry attend. They include LES Annual Meeting, JP Morgan Healthcare, BIO International Convention, AUTM Annual Meeting, as well as several others. Which conferences are attended vary across offices, but one of the largest, most used functions of these conferences is the partnering meeting. Partnering meetings allow face-to-face conversations between members of different organizations that have mutual interests. Some call it “speed dating”—each meeting is scheduled for approximately 30 minutes and they may run back-to-back throughout the day (with little or no breaks for the adventurous). For some it’s tiring, others exhilarating, but it’s always a great way to make connections. Most conferences utilize an online system to schedule meetings. The systems have improved over the years, some allowing full customization of individual and organizational profiles, uploading of documents and videos, and contacting individuals in other organizations. Partnering systems are highly convenient because they allow individuals to lay out a schedule and confirm topics of discussion before arriving at the conference. It is important to ensure the people you are contacting are appropriate for your areas of interest and will make for a productive conversation. There can be as

Continue reading

Case Managers’ Reflect on Their Time with TMS

OTT’s first disclosure from Charles “Chip” Epstein, MD related to his work with an iron core stimulation coil was received in the spring of 1995, with a second disclosure related to transcranial magnetic stimulation (TMS) coming along in late 1997. These were not only the early days for the technology but also the early days of our budding Tech Transfer office. The technology looked promising since it was both the first magnetic stimulator to utilize an iron core design which enabled improvements in power efficiency, heat generation, focal stimulation, and costs. Recognizing these benefits, OTT decided to pursue patent protection resulting in two primary patent families; one focused on stimulating the nervous system and the other on stimulating the brain. These two disclosures formed the foundation of technologies licensed to two Emory start-ups Neotonus and Neuronetics and the winding path for a successful TMS treatment for depression began. Originally Neotonus licensed both patent families in late 1996 and launched into product development. The company’s primary focus was on their NeoControl system which was a non-surgical, non-invasive, painless treatment for female urinary incontinence also involving TMS. The system received FDA clearance in 2000. When Neuronetics came along in 2001, it was

Continue reading

The Personal Side of a Tech Transfer Patient Video

AUTM (Association of University Technology Managers), our professional association, started a program called “Put a Face On It” three years ago with the goal of making a real-world connection between our members’ work and its ability to transform people’s lives. We were excited for the opportunity. Our first project was about a cardiac imaging toolbox. We had a great story – the inventor and patient were the very same person; he had his own invention used on himself before his by-pass surgery (see the video here). The story has been a rousing success. At Emory we are blessed to have a number of worthwhile innovations that have made a difference in people’s lives. The challenge for video number two was selecting one of those stories and finding a willing patient to participate. It’s not as easy as it might sound at first. If the technology is a diagnostic – How do you find a patient when the technology was just a part of the process to get treatment? If the technology is a surgical device – Does the patient know it was used and do they understand the importance of its role? One of the ideas floated after much discussion

Continue reading

September is Research Tools Month Again!

For the 4th year in row, OTT is using September to promote our research tools by highlighting these innovations in our blog, on our website, and on social media. Each year hundreds of new innovations are disclosed by the faculty here at Emory. It is our role to manage these innovations, guiding them from the lab bench to the hands of a commercial partner. An often overlooked piece of the commercialization puzzle is the numerous research tools (cell lines, antibodies, plasmids, research software, etc.) that are also created and shared with many groups and other researchers. We received 43 new research tool disclosures in FY15 and currently have more than 230 tools available for licensing; over a third of those are antibodies. These tools form the workhorses of bench research and are critical components in facilitating discovery. Additionally, they can serve as an additional financial resource for both the University and the scientist in support of the research enterprise. The University has averaged $500,000 in revenue from research tools over the past ten years. This revenue also supports the scientist and their lab by providing additional discretionary revenue in support of their research. Over the past ten year’s more than

Continue reading

It’s All BIO All Week 2015!

Emory OTT will be at the BIO International Convention, the largest conference for the biotech industry, in Philadelphia, PA birthplace of the United States and home of the Liberty Bell. Four members from our office, Executive Director Todd Sherer, Gayathri Srinivasan from the industry relations team, Panya Taysavang from the licensing team, and Quentin Thomas from the marketing team will all be there. It looks to be a busy and productive week! Our booth will be within the Georgia Pavilion again this year (Booth 2101). Someone from the team will be there each day and we look forward to visiting with old friends and making new ones. If you want an easy way to find us, click and use BIO’s handy map. The team has more than 30 partnering meetings set-up prior to flying north. We expect to have many great conversations about Emory research, technology, and start-ups.   This week’s blog will be similar to last year’s BIO blog – each morning our blog will be updated with highlights and points of interest from the BIO meeting the previous day. We will also be tweeting up a storm too (@EmoryOTT), starting conversations & joining in on others. We hope you tune

Continue reading

May is National Cancer Research Month

Cancer has been part of the human condition since the beginning of recorded time. What are believed to be the first descriptions were found in an ancient Egyptian surgical medical textbook from 3000 BC. Today, cancer continues to be a national health menace. Even with the many advances in treatment and care, it remains the second most common cause of death with over 585,720 cancer deaths and 1,665,540 new cancer cases diagnosed in 2014. This month in our social media, the focus will be on cancer. So, why cancer you ask? Emory has a deep commitment to cancer research and patient care. One of the most prominent signs of the University’s commitment to cancer research and patient care is the Winship Cancer Institute of Emory University, the only National Cancer Institute (NCI) designated cancer center in Georgia. (Join us in one of our next blogs to find out more about Winship.) Also, while there are now more than 20 awareness days, weeks, or months around cancer, May just happens to be National Cancer Research Month (follow #NCRM15 this month on Twitter),[i] so we are taking this opportunity to help build awareness around the ways Emory is impacting cancer research. In

Continue reading

AUTM Partnering with Companies – An Evolution

Tech transfer professionals were clamoring for more opportunities to meet with industry representatives. To address this request, the Association of University Technology Managers (AUTM) began a program during its annual meetings to help tech transfer offices to connect with industry. Since its start at the AUTM annual meeting in 2012, the program and its resulting partnering meetings have grown in popularity year over year. What started out as an experiment has grown into a staple and exceptionally valuable part of AUTM’s annual meetings. Our office has jumped at the chance to speak with companies about the exciting technologies spinning out of our labs. Over the years, both the quality and quantity of the meetings have seen a significant increase. Even the web- and mobile-platforms in which we meet and schedule meetings have improved over the years! As both sides (universities & companies) gained experience with speaking to one another, the level of sophistication during these discussions has improved as well. Early conversations were often focused on in-licensing or tech scouting opportunities. Meetings soon evolved toward a more holistic discussion of collaboration and “creative partnerships” to adapt to the ever-changing environment in which we do business. Recently those creative partnerships have

Continue reading

Battling HBV with Building Blocks of DNA

Throughout January we will be highlighting Emory’s and OTT’s work in infectious disease and vaccines. The second technology we are highlighting is Tyzeka®a drug to address Hepatitis B.  The Hepatitis B virus inflames the liver and is one of the top ten killers worldwide. About 350 million people, about 5 percent of the world’s population, are chronic carriers, and thousands die each year from complications of chronic hepatitis B virus (HBV) infections, such as cirrhosis or liver cancer. Thankfully deaths are on the decline due to better treatment options including a vaccination. However for HBV patients who show signs of liver damage, are pregnant, or who have HIV as well, the medications normally used to treat HBV might do more harm than good. In fact, for someone co-infected with HIV, treatment with other HBV drugs could result in resistant HIV. Emory researcher, Raymond Schinazi, invented telbivudine (to help this group of patients that couldn’t be treated with existing HBV treatment options. Telbivudine is a synthetic analogue of the thymidine nucleoside, one of the major building blocks of DNA. Telbivudine (marketed as Tyzeka®) decreases the amount of HBV in the body and is the only FDA-approved hepatitis B drug that is selectively active

Continue reading

SORTing it Out

Throughout January we will be highlighting Emory’s and OTT’s work in infectious disease and vaccines. The ground breaking work begins in the Division of Infectious Disease and the Emory Vaccine Center. The Division of Infectious Disease has 59 faculty and 13 fellows, 5 administrators, and 89 research staff. There are 14 Professors, 7 Associate Professors, 34 Assistant Professors, and 4 Senior Associates or Instructors. The Division is proud of its outstanding accomplishments in a broad spectrum of research, including basic, translational, clinical, and epidemiologic sciences. The Division had more than $30 million in research funding in fiscal year 2013. (For more information: http://medicine.emory.edu/divisions/infectious_diseases/.) The Emory Vaccine Center is an epicenter of academic research and development of vaccines for both chronic and infectious diseases. With more than 250 faculty members and staff, it is the largest and most comprehensive academic vaccine research center in the world. The Center is making fundamental advances in immunology, virology, and vaccine research to search for life saving cures against the world’s most threatening diseases plaguing millions of individuals around the globe. (For more information: http://www.vaccines.emory.edu/.) The first technology we are highlighting is SORT. There’s a very real fear in the healthcare world that during a

Continue reading